Additional fibrate treatment in UDCA‐refractory PBC patients-Reference-Cited by-同舟云学术

Additional fibrate treatment in UDCA‐refractory PBC patients

Published:2019-07-02 Issue:9 Volume:39 Page:1776-1785
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Chung Sung Won¹^ORCID,Lee Jeong‐Hoon¹^ORCID,Kim Minseok Albert¹^ORCID,Leem Galam²,Kim Sun Woong¹,Chang Young¹,Lee Hyo Young¹,Yoon Jun Sik¹³,Park Jun Yong²^ORCID,Lee Yun Bin¹^ORCID,Cho Eun Ju¹^ORCID,Yu Su Jong¹,Kim Yoon Jun¹^ORCID,Yoon Jung‐Hwan¹

Affiliation:

1. Department of Internal Medicine and Liver Research Institute Seoul National University College of Medicine Seoul Korea

2. Department of Internal Medicine Yonsei University College of Medicine, Yonsei Liver Center, Severance Hospital Seoul Korea

3. Department of Internal Medicine Busan Paik Hospital, Inje University College of Medicine Busan Korea

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14165

Reference55 articles.

1. Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases;Lindor KD;Hepatology,2018

2. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

3. Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea

4. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study

5. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid;Gastroenterología y Hepatología;2023-11

2. Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid;Gastroenterología y Hepatología (English Edition);2023-11

3. Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis;Hepatology Research;2023-09-27

4. Effectiveness of Fenofibrate in Treatment-Naive Patients With Primary Biliary Cholangitis: A Randomized Clinical Trial;American Journal of Gastroenterology;2023-03-09

5. Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview;Nutrients;2023-02-02